insights_auto
Nega NTRA oshdi 2,54%?
Batafsil oʻrganishchevron_right
NTRA:NASDAQ
Natera Inc
400,71 US$
arrow_upward
+2,54%(+9,92) 1K
400,71 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 9-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoNTRA tikeri uchun statistika yaratilmoqda...
Ochish
392,90 US$
Yuqori
407,06 US$
Past
391,51 US$
Bozor kapitali
57,76 mlrd
Oʻrtacha hajm
1,64 mln
Hajmi
1,01 mln
52 haftalik eng yuqori
437,41 US$
52 haftalik eng past
167,98 US$
Aksiya boʻyicha daromad
-1,37 US$
Beta
1,50
Muomaladagi aksiyalar
144,14 mln
Xodimlar soni
6 ming
Ochish
392,90 US$
Yuqori
407,06 US$
Past
391,51 US$
Bozor kapitali
57,76 mlrd
Oʻrtacha hajm
1,64 mln
Hajmi
1,01 mln
52 haftalik eng yuqori
437,41 US$
52 haftalik eng past
167,98 US$
Aksiya boʻyicha daromad
-1,37 US$
Beta
1,50
Muomaladagi aksiyalar
144,14 mln
Xodimlar soni
6 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
5 soat oldin
Natera stock trades at EUR 359.55 with a minus 296.1 P/ E
StockStory
·
6 soat oldin
Why Natera (NTRA) Stock Is Up Today
AD HOC NEWS
·
7 soat oldin
Natera enrolls melanoma trial patients. Natera stock gains 2.75 percent
Investing.com
·
10 soat oldin
Natera receives FDA breakthrough designation for cancer test
Profil
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Natera Inc haqida
CEOSteven Chapman
Xodimlar soni6,14 ming
Asos solingan1-yan, 2004
Bosh ofislarOstin, Texas, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytnatera.com